Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperphosphatemia and diet therapy].

Noriyuki Okada1, Yasumasa Kasai, Yoshiharu Tsubakihara

  • 1Division of Clinical Laboratory, Osaka Prefectural General Hospital.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Controlling serum phosphate is crucial for hemodialysis patients to prevent bone disease and improve outcomes. Dietary management, including low-phosphate foods and protein intake, is essential for better prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between serum lactate dehydrogenase level and renal outcome in patients with advanced chronic kidney disease without diabetes mellitus.

Clinical and experimental nephrology·2026
Same author

Infrared Near-Field Spectroscopy of AlGaN/GaN Heterostructures for Probing Two-Dimensional Electron Gas.

ACS applied materials & interfaces·2025
Same author

Difelikefalin for Hemodialysis Patients with Pruritus in Japan.

NEJM evidence·2024
Same author

Higher hemoglobin levels using darbepoetin alfa and kidney outcomes in advanced chronic kidney disease without diabetes: a prespecified secondary analysis of the PREDICT trial.

Clinical and experimental nephrology·2023
Same author

Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.

PloS one·2022
Same author

Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis: A Randomized Clinical Trial.

JAMA network open·2022

Area of Science:

  • Nephrology
  • Clinical Nutrition

Context:

  • Hyperphosphatemia is a significant complication in hemodialysis patients, linked to renal bone disease and adverse prognosis.
  • Current management often involves phosphate binders, but dietary phosphate restriction is also critical.

Purpose:

  • To highlight the importance of dietary phosphate control in hemodialysis patients.
  • To emphasize the need for low phosphate-to-protein ratio foods and avoidance of additives.

Summary:

  • Serum phosphate control is vital for hemodialysis patients, impacting bone health and survival.
  • Patients require adequate protein intake, necessitating careful selection of low-phosphate, low phosphate/protein ratio foods.
  • Restricting processed foods, confectioneries, and seasonings containing phosphate additives is recommended. Special low-phosphate foods may be beneficial.

Impact:

  • Improved patient outcomes and prognosis in hemodialysis through targeted dietary interventions.
  • Enhanced understanding of the relationship between protein intake, phosphate content, and food choices in renal patients.

Related Experiment Videos